Vertex Pharmaceuticals (VRTX) Cash & Equivalents Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 214.58% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 17.50% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -4.13% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 3.35% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 67.78% |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.50% |
| Dec 31, 2025 | 11.27% |
| Sep 30, 2025 | -5.72% |
| Jun 30, 2025 | 8.56% |
| Mar 31, 2025 | -48.96% |
| Dec 31, 2024 | -55.93% |
| Sep 30, 2024 | -52.84% |
| Jun 30, 2024 | -54.88% |
| Mar 31, 2024 | -1.42% |
| Dec 31, 2023 | -1.28% |
| Sep 30, 2023 | 21.14% |
| Jun 30, 2023 | 16.65% |
| Mar 31, 2023 | 22.23% |
| Dec 31, 2022 | 54.58% |
| Sep 30, 2022 | 46.14% |
| Jun 30, 2022 | 43.51% |
| Mar 31, 2022 | 20.55% |
| Dec 31, 2021 | 13.47% |
| Sep 30, 2021 | 17.13% |
| Jun 30, 2021 | 25.51% |
| Mar 31, 2021 | 75.44% |
| Dec 31, 2020 | 92.59% |
| Sep 30, 2020 | 57.69% |
| Jun 30, 2020 | 46.64% |
| Mar 31, 2020 | 24.17% |
| Dec 31, 2019 | 17.33% |
| Sep 30, 2019 | 37.11% |
| Jun 30, 2019 | 53.57% |
| Mar 31, 2019 | 44.99% |
| Dec 31, 2018 | 59.13% |
| Sep 30, 2018 | 78.94% |
| Jun 30, 2018 | 75.40% |
| Mar 31, 2018 | 4,378.71% |
| Dec 31, 2017 | 40.67% |
| Sep 30, 2017 | 92.44% |
| Jun 30, 2017 | 101.88% |
| Mar 31, 2017 | -92.62% |
| Dec 31, 2016 | 65.64% |
| Sep 30, 2016 | -4.83% |
| Jun 30, 2016 | -30.40% |